Healthcare and Biotech as Contrarian Opportunities

RenMac digs into a complicated January jobs report that dampens near-term rate-cut expectations as Dutta warns that unemployment risks are rising beneath stable headlines, while deGraaf points to an updated Market Cycle Clock, falling yields and trend signals that still support equities. Pavlick outlines growing policy uncertainty around tariffs, housing affordability, and Venezuela, and the team explores why markets continue to shrug off geopolitical risk, how healthcare and biotech are emerging as contrarian opportunities, and what investors should watch for as earnings season and inflation data take center stage.